MeSH tree: C12.050.351.968.934.734
A new doctoral thesis recently published by Giorgi Beridze at Karolinska Institutet sheds light on the relationship between multimorbidity and kidney health in older adults. The research explores how kidney function is ascertained ...
Oct 28, 2025
0
9
A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a University of Bristol ...
Oct 14, 2025
0
26
A new study shows that people with higher levels of the protein albumin in their urine are at increased risk of developing dementia. The study, led by researchers at Karolinska Institutet, is published in the Journal of Internal ...
Sep 24, 2025
0
27
A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for people with hard-to-treat hypertension. The medication, baxdrostat, reduces the levels of a hormone ...
Sep 17, 2025
0
17
A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of kidney disease in people with both conditions.
Sep 14, 2025
0
23
Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high blood pressure , according ...
Sep 6, 2025
0
27
A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated activity of cdc42 is a critical initiation event leading to proteinuria, and proposed that suppression ...
Aug 7, 2025
0
7
The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).
Aug 4, 2025
0
20
New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN). Findings presented ...
Jun 5, 2025
0
14
Hypertension affects more than one-third of the global adult population and is a leading contributor to early death from cardiovascular and other chronic diseases. While treatments for high blood pressure are widely available, ...
Apr 28, 2025
0
14
